Evidence map›Paper›PMID 16977311›Full record

ArticleThe EMBO journal2006

Opposing roles for Set2 and yFACT in regulating TBP binding at promoters.

Debabrata Biswas, Rinku Dutta-Biswas, Doyel Mitra, Yoichiro Shibata, Brian D Strahl, Tim Formosa, David J Stillman

Open access · bronzeAbstract read
In one paragraph

Article in The EMBO journal, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 51 papers.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

51 citing papers in PubMed, 74 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Structure and function of the histone chaperone FACT - Resolving FACTual issues.Biochimica et biophysica acta. Gene regulatory mechanisms · 2018
    Review
  12. Article
  13. FACT complex is required for DNA demethylation at heterochromatin during reproduction inProceedings of the National Academy of Sciences of the United States of America · 2018
    Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Debabrata BiswasDepartment of Pathology, University of Utah Health Sciences Center, Salt Lake City, 84112, USA.
Rinku Dutta-Biswas
Doyel Mitra
Yoichiro Shibata
Brian D Strahl
Tim Formosa
David J Stillman
University of Utah · USUniversity of North Carolina at Chapel Hill · USUtah Department of Health · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Previous work links histone methylation by Set2 with transcriptional elongation. yFACT (Spt16-Pob3 and Nhp6) reorganizes nucleosomes and functions in both transcriptional initiation and elongation. We show that growth defects caused by spt16 or pob3 mutations can be suppressed by deleting SET2, suggesting that Set2 and yFACT have opposing roles. Set2 methylates K36 of histone H3, and K36 substitutions also suppress yFACT mutations. In contrast, set1 enhances yFACT mutations. Methylation at H3 K4 by Set1 is required for set2 to suppress yFACT defects. We did not detect an elongation defect at an 8 kb ORF in yFACT mutants. Instead, pob3 mutants displayed reduced binding of both pol II and TBP to the GAL1 promoter. Importantly, both GAL1 transcription and promoter binding of pol II and TBP are significantly restored in the pob3 set2 double mutant. Defects caused by an spt16 mutation are enhanced by either TBP or TFIIA mutants. These synthetic defects are suppressed by set2, demonstrating that yFACT and Set2 oppose one another during transcriptional initiation at a step involving DNA binding by TBP and TFIIA.

Indexed as

Amino Acid SubstitutionCarrier ProteinsCell Cycle ProteinsDNA-Binding ProteinsEpistasis, GeneticGene Expression Regulation, FungalHistone-Lysine N-MethyltransferaseHistonesMethylationMethyltransferasesMutant ProteinsMutationPhenotypePromoter Regions, GeneticProtein BindingRNA Polymerase IICarrier ProteinsCell Cycle ProteinsDNA-Binding ProteinsHistone-Lysine N-MethyltransferaseHistonesMethyltransferasesMutant ProteinsPOB3 protein, S cerevisiaeRNA Polymerase IISaccharomyces cerevisiae ProteinsSET1 protein, S cerevisiaeSet2 protein, S cerevisiaeSPT16 protein, S cerevisiaeTATA-Box Binding ProteinTranscriptional Elongation FactorsTranscription FactorsTranscription Factor TFIIA

Identifiers

PMID16977311
PMCPMC1589996
OpenAlexW2034285022

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.